|
|
Volumn 3, Issue 12, 2006, Pages 641-
|
|
A step in the right direction
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
GEMCITABINE;
ADJUVANT THERAPY;
APOPTOSIS;
BREAST CANCER;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER MORTALITY;
CANCER PATIENT;
CANCER STAGING;
CANCER SURVIVAL;
CELL GROWTH;
CLINICAL TRIAL;
COLORECTAL CANCER;
DISEASE FREE SURVIVAL;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SCREENING;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GENE MUTATION;
GENE TRANSLOCATION;
GENETIC STABILITY;
GOLD STANDARD;
HUMAN;
HYPOTHESIS;
MALIGNANT NEOPLASTIC DISEASE;
METASTASIS POTENTIAL;
OUTCOME ASSESSMENT;
OVARY CANCER;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTIMETABOLITES, ANTINEOPLASTIC;
DEOXYCYTIDINE;
DRUG APPROVAL;
ENDPOINT DETERMINATION;
FEMALE;
HUMANS;
NEOPLASMS;
OVARIAN NEOPLASMS;
SURVIVAL ANALYSIS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33751584863
PISSN: 17434254
EISSN: 17434262
Source Type: Journal
DOI: 10.1038/ncponc0669 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|